Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Ulcerative Colitis 1.4.3 Crohns Disease 1.4.4 Others 1.5 Market by Application 1.5.1 Global Inflammatory Bowel Disease Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Medical Research Organization 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Inflammatory Bowel Disease Therapy Market Perspective (2015-2026) 2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions 2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Inflammatory Bowel Disease Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Inflammatory Bowel Disease Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Inflammatory Bowel Disease Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Inflammatory Bowel Disease Therapy Players by Market Size 3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2015-2020) 3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio 3.2.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2019 3.3 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served 3.4 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service 3.5 Date of Enter into Inflammatory Bowel Disease Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2015-2020) 4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2021-2026) 5 Inflammatory Bowel Disease Therapy Breakdown Data by Application (2015-2026) 5.1 Global Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Inflammatory Bowel Disease Therapy Market Size (2015-2020) 6.2 Inflammatory Bowel Disease Therapy Key Players in North America (2019-2020) 6.3 North America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 6.4 North America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2015-2020) 7.2 Inflammatory Bowel Disease Therapy Key Players in Europe (2019-2020) 7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 8 China 8.1 China Inflammatory Bowel Disease Therapy Market Size (2015-2020) 8.2 Inflammatory Bowel Disease Therapy Key Players in China (2019-2020) 8.3 China Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 8.4 China Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Inflammatory Bowel Disease Therapy Market Size (2015-2020) 9.2 Inflammatory Bowel Disease Therapy Key Players in Japan (2019-2020) 9.3 Japan Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 9.4 Japan Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Inflammatory Bowel Disease Therapy Market Size (2015-2020) 10.2 Inflammatory Bowel Disease Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 11 India 11.1 India Inflammatory Bowel Disease Therapy Market Size (2015-2020) 11.2 Inflammatory Bowel Disease Therapy Key Players in India (2019-2020) 11.3 India Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 11.4 India Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Inflammatory Bowel Disease Therapy Market Size (2015-2020) 12.2 Inflammatory Bowel Disease Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) 12.4 Central & South America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Johnson & Johnson 13.1.1 Johnson & Johnson Company Details 13.1.2 Johnson & Johnson Business Overview and Its Total Revenue 13.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction 13.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)) 13.1.5 Johnson & Johnson Recent Development 13.2 AbbVie 13.2.1 AbbVie Company Details 13.2.2 AbbVie Business Overview and Its Total Revenue 13.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction 13.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.2.5 AbbVie Recent Development 13.3 Takeda Pharmaceutical Company 13.3.1 Takeda Pharmaceutical Company Company Details 13.3.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue 13.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction 13.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.3.5 Takeda Pharmaceutical Company Recent Development 13.4 Abbott 13.4.1 Abbott Company Details 13.4.2 Abbott Business Overview and Its Total Revenue 13.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction 13.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.4.5 Abbott Recent Development 13.5 Celgene Corporation 13.5.1 Celgene Corporation Company Details 13.5.2 Celgene Corporation Business Overview and Its Total Revenue 13.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction 13.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.5.5 Celgene Corporation Recent Development 13.6 Innovate Biopharma 13.6.1 Innovate Biopharma Company Details 13.6.2 Innovate Biopharma Business Overview and Its Total Revenue 13.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction 13.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.6.5 Innovate Biopharma Recent Development 13.7 Cosmo Pharmaceuticals 13.7.1 Cosmo Pharmaceuticals Company Details 13.7.2 Cosmo Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction 13.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.7.5 Cosmo Pharmaceuticals Recent Development 13.8 Gilead Sciences 13.8.1 Gilead Sciences Company Details 13.8.2 Gilead Sciences Business Overview and Its Total Revenue 13.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction 13.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.8.5 Gilead Sciences Recent Development 13.9 Pfizer 13.9.1 Pfizer Company Details 13.9.2 Pfizer Business Overview and Its Total Revenue 13.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction 13.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) 13.9.5 Pfizer Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Inflammatory Bowel Disease Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue Table 3. Ranking of Global Top Inflammatory Bowel Disease Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Ulcerative Colitis Table 6. Key Players of Crohns Disease Table 7. Key Players of Others Table 8. Global Inflammatory Bowel Disease Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Inflammatory Bowel Disease Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Inflammatory Bowel Disease Therapy Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2015-2020) Table 12. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Inflammatory Bowel Disease Therapy Market Growth Strategy Table 18. Main Points Interviewed from Key Inflammatory Bowel Disease Therapy Players Table 19. Global Inflammatory Bowel Disease Therapy Revenue by Players (2015-2020) (Million US$) Table 20. Global Inflammatory Bowel Disease Therapy Market Share by Players (2015-2020) Table 21. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2019) Table 22. Global Inflammatory Bowel Disease Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Inflammatory Bowel Disease Therapy Product Solution and Service Table 25. Date of Enter into Inflammatory Bowel Disease Therapy Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 28. Global Inflammatory Bowel Disease Therapy Market Size Share by Type (2015-2020) Table 29. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2015-2020) Table 31. Global Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 32. Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2021-2026) Table 33. North America Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 34. North America Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 35. North America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 36. North America Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 37. North America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 38. North America Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 39. Europe Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 41. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 42. Europe Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 43. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 44. Europe Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 45. China Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 46. China Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 47. China Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 48. China Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 49. China Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 50. China Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 51. Japan Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 53. Japan Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Japan Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 55. Japan Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Japan Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 59. Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 61. Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 63. India Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 64. India Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 65. India Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 66. India Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 67. India Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 68. India Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 69. Central & South America Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020) Table 71. Central & South America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020) Table 73. Central & South America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020) Table 75. Johnson & Johnson Company Details Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Product Table 78. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 79. Johnson & Johnson Recent Development Table 80. AbbVie Company Details Table 81. AbbVie Business Overview Table 82. AbbVie Product Table 83. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 84. AbbVie Recent Development Table 85. Takeda Pharmaceutical Company Company Details Table 86. Takeda Pharmaceutical Company Business Overview Table 87. Takeda Pharmaceutical Company Product Table 88. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 89. Takeda Pharmaceutical Company Recent Development Table 90. Abbott Company Details Table 91. Abbott Business Overview Table 92. Abbott Product Table 93. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 94. Abbott Recent Development Table 95. Celgene Corporation Company Details Table 96. Celgene Corporation Business Overview Table 97. Celgene Corporation Product Table 98. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 99. Celgene Corporation Recent Development Table 100. Innovate Biopharma Company Details Table 101. Innovate Biopharma Business Overview Table 102. Innovate Biopharma Product Table 103. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 104. Innovate Biopharma Recent Development Table 105. Cosmo Pharmaceuticals Company Details Table 106. Cosmo Pharmaceuticals Business Overview Table 107. Cosmo Pharmaceuticals Product Table 108. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 109. Cosmo Pharmaceuticals Recent Development Table 110. Gilead Sciences Business Overview Table 111. Gilead Sciences Product Table 112. Gilead Sciences Company Details Table 113. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 114. Gilead Sciences Recent Development Table 115. Pfizer Company Details Table 116. Pfizer Business Overview Table 117. Pfizer Product Table 118. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$) Table 119. Pfizer Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2020 VS 2026 Figure 2. Ulcerative Colitis Features Figure 3. Crohns Disease Features Figure 4. Others Features Figure 5. Global Inflammatory Bowel Disease Therapy Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Medical Research Organization Case Studies Figure 8. Other Case Studies Figure 9. Inflammatory Bowel Disease Therapy Report Years Considered Figure 10. Global Inflammatory Bowel Disease Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Inflammatory Bowel Disease Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2019 Figure 15. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2019 Figure 17. North America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 26. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 28. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 32. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 34. Innovate Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 36. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 38. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 40. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

Johnson & Johnson AbbVie Takeda Pharmaceutical Company Abbott Celgene Corporation Innovate Biopharma Cosmo Pharmaceuticals Gilead Sciences Pfizer